HCSGD entry for CD14
1. General information
Official gene symbol | CD14 |
---|---|
Entrez ID | 929 |
Gene full name | CD14 molecule |
Other gene symbols | |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in PPI subnetwork.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0001530 | Lipopolysaccharide binding | IDA | molecular_function |
GO:0001847 | Opsonin receptor activity | TAS | molecular_function |
GO:0002224 | Toll-like receptor signaling pathway | TAS | biological_process |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | TAS | biological_process |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | TAS | biological_process |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005576 | Extracellular region | TAS | cellular_component |
GO:0005615 | Extracellular space | IEA | cellular_component |
GO:0005886 | Plasma membrane | IEA TAS | cellular_component |
GO:0006909 | Phagocytosis | TAS | biological_process |
GO:0006915 | Apoptotic process | TAS | biological_process |
GO:0006954 | Inflammatory response | IEA | biological_process |
GO:0007166 | Cell surface receptor signaling pathway | TAS | biological_process |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | TAS | biological_process |
GO:0009408 | Response to heat | IEA | biological_process |
GO:0009986 | Cell surface | IEA | cellular_component |
GO:0010008 | Endosome membrane | TAS | cellular_component |
GO:0016019 | Peptidoglycan receptor activity | TAS | molecular_function |
GO:0031225 | Anchored component of membrane | IEA | cellular_component |
GO:0032026 | Response to magnesium ion | IEA | biological_process |
GO:0032760 | Positive regulation of tumor necrosis factor production | IDA | biological_process |
GO:0034134 | Toll-like receptor 2 signaling pathway | TAS | biological_process |
GO:0034138 | Toll-like receptor 3 signaling pathway | TAS | biological_process |
GO:0034142 | Toll-like receptor 4 signaling pathway | TAS | biological_process |
GO:0034612 | Response to tumor necrosis factor | IEA | biological_process |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | TAS | biological_process |
GO:0038123 | Toll-like receptor TLR1:TLR2 signaling pathway | TAS | biological_process |
GO:0038124 | Toll-like receptor TLR6:TLR2 signaling pathway | TAS | biological_process |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0045121 | Membrane raft | IEA | cellular_component |
GO:0045471 | Response to ethanol | IEA | biological_process |
GO:0045807 | Positive regulation of endocytosis | IEA | biological_process |
GO:0050715 | Positive regulation of cytokine secretion | IEA | biological_process |
GO:0070891 | Lipoteichoic acid binding | IDA | molecular_function |
GO:0071222 | Cellular response to lipopolysaccharide | IDA IEA | biological_process |
GO:0071223 | Cellular response to lipoteichoic acid | IDA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0359027621 | 0.4933043197 | 0.4316536331 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.2436814538 |
GSE13712_SHEAR | Down | -1.2615820946 |
GSE13712_STATIC | Up | 0.0313447367 |
GSE19018 | Up | 0.0131300212 |
GSE19899_A1 | Down | -0.0918421501 |
GSE19899_A2 | Up | 0.3779773708 |
PubMed_21979375_A1 | Up | 0.1054860127 |
PubMed_21979375_A2 | Down | -0.0344883903 |
GSE35957 | Up | 2.2020249239 |
GSE36640 | Up | 0.4066079434 |
GSE54402 | Down | -0.0318315992 |
GSE9593 | Up | 1.0537337321 |
GSE43922 | Up | 0.0358261604 |
GSE24585 | Up | 0.0790607154 |
GSE37065 | Up | 0.3228252433 |
GSE28863_A1 | Up | 0.4481286998 |
GSE28863_A2 | Up | 0.4980395254 |
GSE28863_A3 | Down | -0.0078854802 |
GSE28863_A4 | Down | -0.0811552368 |
GSE48662 | Up | 0.4712199758 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-335-5p | MIMAT0000765 | MIRT016817 | Microarray | Functional MTI (Weak) | 18185580 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
- mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 9 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
27073222 | RESULTS: Cases had lower CD4(+) T-cell counts, higher CD8(+) T-cell counts, and increased levels of immune activation (ie, increased soluble CD14 [sCD14] level and increased percentages of CD38(+)HLA-DR(+) cells among both CD4(+) and CD8(+) T cells), regulatory T cells, and percentage of programmed cell death 1 (PD-1)-expressing cells among CD4(+) T cells |
27073222 | The increased soluble CD14 levels and percentage of CD38(+)HLA-DR(+) cells among CD4(+) T cells correlated with shorter telomeres and increased regulatory T-cell levels |
26196672 | CD14 was expressed at low levels on OK3 and OK3H and HLA-DR on BMA13 (84 |
25604328 | Immunosenescence was investigated by analysing CD57(+) CD28(-) levels, immune activation by analysing CD38(+) HLA-DR(+) levels, inflammation by analysing interleukin (IL)-6 levels, and microbial translocation by analysing lipopolysaccharide (LPS) and soluble CD14 (sCD14) levels |
23974111 | Erlotinib and gefitinib alone did not promote differentiation, yet stimulated the acquisition of morphological and biochemical maturation markers (including the expression of CD11b and CD14 as well as increased NADPH oxidase activity) when combined with either ATRA or VD |
22948867 | MVC-specific effects in patients with virological responses included increased CD8(+) T-cell activation and senescence levels, preservation of an increase in soluble CD14 (sCD14), and a decrease in D dimer levels |
17951672 | Surface markers that can be used to characterize FLS include positive staining for VCAM-1, CD44, CD55, CD90 (Thy-1), and cadherin-11, coupled with the absence of macrophage markers such as CD14 or CD68 |
16955214 | Enforced stable over-expression of CLU in K562 cells inhibited the expression of the CD14 differentiation marker and blocked differentiation to either monocytes/megacaryoblasts or to erythrocytes |
15685514 | Expression of p53, CD14/CD16, and intracellular cytokine production (interleukin-1beta [IL-1beta], IL-6, and IL-4) was evaluated by means of flow cytometry using specific antibodies |
12803109 | RESULTS: L-C increases HLA-DR and CD14 surface antigens, while morphologic and marker analysis of the treated cells reveals the presence of monocytes, neutrophiles and few dendritic cells |
Entries Per Page
Displaying Page of